Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

New MRI Scans for Finding Bone Damage in Multiple Myeloma

Tests new whole-body MRI scans to detect bone lesions in adults with myeloma.

Plain-language title generated from the registry record
Registry title: "Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma

Key facts

Where
Brussels, BelgiumSee the site

Where in Belgium

  • Cliniques universitaires Saint-LucBrussels, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Trial code
NCT06988020
Record updated
24 April 2026
Original description
Recent work has confirmed the diagnostic performance of pseudo-CT sequences for detecting osteolytic lesions. Their integration into whole body MRI (WB MRI) could transform the diagnostic approach to MM, by allowing a combined assessment of bone marrow involvement, tissue viability and osteolysis, during a single non-irradiating imaging examination. Since the preliminary work mentioned above, optimizations have been made to the pseudo-CT sequences, including the addition of deep learning (correcting noise in the images) and the correction of chemical shift artifact (linked to the coexistence of hydrated tissue and fatty tissue), which carry real hope of improving their diagnostic potential and accuracy.Read full original descriptionShow less

Evaluation of Optimised Whole-body MRI Examinations Incorporating "Pseudo-scanner" Sequences (ZTE, "Zero Echo Time" AND Lava Flex) for the Detection of Bone Lesions in Multiple Myeloma

Recent work has confirmed the diagnostic performance of pseudo-CT sequences for detecting osteolytic lesions. Their integration into whole body MRI (WB MRI) could transform the diagnostic approach to MM, by allowing a combined assessment of bone marrow involvement, tissue viability and osteolysis, during a single non-irradiating imaging examination. Since the preliminary work mentioned above, optimizations have been made to the pseudo-CT sequences, including the addition of deep learning (correcting noise in the images) and the correction of chemical shift artifact (linked to the coexistence of hydrated tissue and fatty tissue), which carry real hope of improving their diagnostic potential and accuracy.

Inclusion: Patient with newly diagnosed multiple myeloma, for whom bone imaging is required for staging; Recurrent patient after intensive treatment (high dose chemotherapy, bone marrow transplant, etc.); Patient requiring a PET / CT considered as the technique of choice in these stages of the disease.

Exclusion: Implanted material incompatible with MRI; Severe claustrophobia; Pregnant women.

ClinicalTrials.gov NCT06988020